Minor1,5-benzodiazepine antiepileptic×Second-generation antihistamine
Updated · Methodology
Mechanism
Clobazam is rapidly metabolised in the liver, mainly by CYP3A4 and to a lesser extent by CYP2C19, to active N-desmethylclobazam, and is excreted in urine and faeces (Silocalm SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 5.2). Its SmPC warns that CNS depression may increase when clobazam is combined with antipsychotics, hypnotics, anxiolytics or sedatives, certain antidepressants, narcotic analgesics, anticonvulsants, anaesthetics and sedating antihistamines (AEMPS, section 4.5). Fexofenadine is barely metabolised, does not interact through hepatic mechanisms, and its exposure is changed by P-gp modulators (fexofenadine SmPC, AEMPS, sections 4.5 and 5.2). According to its SmPC, fexofenadine is a non-sedating antihistamine that is unlikely to affect the ability to drive (AEMPS, sections 4.7 and 5.1), so it does not belong to the sedating antihistamines named in the clobazam SmPC.
Symptoms
The documents describe no symptoms caused by this combination. Clobazam causes sedation and can depress breathing. Like other benzodiazepines, it can lead to physical and psychological dependence, and the risk increases with dose and duration (Silocalm SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 4.4). Common adverse effects of fexofenadine are headache, somnolence, dizziness and nausea (fexofenadine SmPC, AEMPS, section 4.8).
Management
According to the documents, the combination is acceptable and no dose change of clobazam or fexofenadine is needed. Fexofenadine is not one of the sedating antihistamines that call for attention with clobazam (Silocalm and fexofenadine SmPCs, Spanish Agency of Medicines and Medical Devices, AEMPS, sections 4.5 and 5.1). People are advised to check their own response to fexofenadine before driving or doing complex tasks (fexofenadine SmPC, AEMPS, section 4.7). Alcohol taken with clobazam can increase its bioavailability by 50% and strengthen sedation, affecting the ability to drive or use machines (Silocalm SmPC, AEMPS, section 4.5).
Your whole list in one report
Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email
Add more drugsMedicine list: everything you take in one place →
Sources
- AEMPS: Ficha técnica: Fexofenadina, Fexofenadina Opella 180 mg (nº registro 61911), sección 4.5 (2026)– AEMPS, CIMA, nº registro 61911 (Fexofenadina Opella 180 mg comprimidos recubiertos con película, Opella Healthcare Spain), revisión 04/2026, secciones 4.4, 4.5, 4.7, 4.8, 5.1 y 5.2
- AEMPS: Ficha técnica: Clobazam, Silocalm 2 mg/ml suspensión oral (nº registro 81523), sección 4.5 (2026)– AEMPS, CIMA, nº registro 81523 (Silocalm 2 mg/ml suspensión oral), revisión 05/2026, secciones 4.4, 4.5 y 5.2